Company news
Spectral AI, Inc. news in 2024
Spectral AI, Inc.'s news releases, calls and decks from 2024, newest first.
Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants
December 30, 2024
Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements
December 22, 2024
Spectral AI Highlights Unprecedented Collaboration with National Leaders in Burn Care for DeepView™ System Training and Validation Studies
December 11, 2024
Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision
December 8, 2024
Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review
December 1, 2024
Spectral AI Announces Repricing of its Public Warrants
November 25, 2024
Spectral AI Announces DeepView SnapShot® M Moves Forward with Feedback from Brooke Army Medical Center Institute of Surgical Research
November 20, 2024
Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway
November 18, 2024
Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization
November 5, 2024
Spectral AI Announces 2024 Third Quarter Financial Results
November 5, 2024
Spectral AI Announces Last Patient Out in U.S. Burn Pivotal Study at Burn Centers
October 29, 2024
Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
October 22, 2024
Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors
October 13, 2024
Spectral AI Completes Proof of Concept for Wound Measurement Technology
October 2, 2024
Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites
September 23, 2024
Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication
September 16, 2024
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®
September 4, 2024
Spectral AI Completes Burn Center Enrollment for U.S. Burn Pivotal Study
August 26, 2024
Spectral AI Announces Podium Presentation at BBA / ISBI Joint Conference Assessing Burn Wound Severity Using Multispectral Imaging and Artificial Intelligence
August 18, 2024
Spectral AI Announces 2024 Second Quarter Financial Results
August 11, 2024
Spectral AI Announces Continuing Progress in Development of Handheld DeepView SnapShot M® for Military Field Use
July 30, 2024
Spectral AI Schedules 2024 Second Quarter Financial Results and Conference Call
July 28, 2024
Spectral AI Announces Total U.S. and International Patent Portfolio Now Stands at 26 Granted Patents and 38 Pending Applications in Support of its AI-Driven DeepView System
July 23, 2024
Spectral AI Adds Three New Clinical Trial Sites To Expedite Emergency Department Patient Enrollment
July 22, 2024
Spectral AI Announces Collaboration with Global Wound Care Company PolyNovo to Introduce DeepView System for Burn Indication to Australian Market
July 7, 2024
Spectral AI Expands Clinical Trial Sites for Pivotal U.S. Burn Study
July 2, 2024
Spectral AI Achieves 100% Pediatric Enrollment in Burn Centers for Pivotal U.S. Burn Study
July 1, 2024
Spectral AI Joins Russell Microcap® Index
June 30, 2024
Spectral AI Surpasses 90% of Pediatric Enrollment Target in Burn Centers for Pivotal U.S. Burn Study
June 26, 2024
Spectral AI Reaches 50% Enrollment at Burn Centers for U.S. Pivotal Burn Study
June 5, 2024
Spectral AI Set to Join Russell Microcap® Index
May 28, 2024
Spectral AI Announces Purchases of Over 100,000 Shares by Insiders
May 16, 2024
Spectral AI Announces Voting Results from 2024 Annual Meeting of Stockholders and the Appointment of Erich Spangenberg to the Board of Directors
May 14, 2024
Spectral AI Announces 2024 First Quarter Financial Results
May 6, 2024
Spectral AI Awarded Quality Achievement Award from the Texas Manufacturer Assistance Center
April 29, 2024
Spectral AI Schedules 2024 First Quarter Financial Results and Conference Call
April 23, 2024
Spectral AI Appoints Jeremiah Sparks as Chief Commercialization Officer
March 31, 2024
Spectral AI Announces 2023 Fourth Quarter and Full Year Financial Results
March 26, 2024
Spectral AI Secures Access to $12.5 Million of New Equity Capital
March 19, 2024
Spectral AI Announces Receipt of $1 Million of Financing for Spectral IP, Inc., its Intellectual Property Subsidiary Focused on the Broader Artificial Intelligence Ecosystem
March 18, 2024
Spectral AI Schedules 2023 Fourth Quarter and Full Year Financial Results and Conference Call
March 12, 2024
Spectral AI Announces New US Government Contract to Further Accelerate the Development of the Handheld Version of DeepView™ Wound Imaging System
March 11, 2024
Spectral AI Announces Intellectual Property Subsidiary to Focus on the Broader AI Healthcare Ecosystem
March 6, 2024
Spectral AI Appoints Peter M. Carlson as CEO
February 28, 2024
Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
February 21, 2024
Spectral AI Appoints Dr. J. Michael DiMaio to Board of Directors
February 11, 2024
Spectral AI Announces Publication of Letter to Shareholders
February 4, 2024
Spectral Submits Application for UKCA Mark Classification
January 28, 2024
Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries
January 10, 2024
Calls in 2024
Decks in 2024
- Investor Presentation (August 2024)
Investor deck · 32 slides · Aug 13, 2024
- Investor Presentation (February 2024)
Investor deck · 32 slides · Feb 13, 2024